20 40 60 80 100

20

40

60

80

100

Overall Survival (months)

Cu

mu

lati

ve S

urv

ival

(%

)

BM negative

BM positive

P = 0.003

Supplemental file 5Overall survivals and disease free survivals of patients with detectable presentation EBV DNA

A

B

20 40 60 80 100

20

40

60

80

100

Overall Survival (months)

Cu

mu

lati

ve S

urv

ival

(%

)

EBV group A

EBV group B

EBV group C

P < 0.001

20 40 60 80 100

20

40

60

80

100

Overall Survival (months)

Cu

mu

lati

ve S

urv

ival

(%

) KIPI = 0

KIPI = 1

KIPI = 2

KIPI = 3

KIPI = 4

P = 0.001

20 40 60 80 100

20

40

60

80

100

Overall Survival (months)

Cu

mu

lati

ve S

urv

ival

(%

) IPI = 0

IPI = 1

IPI = 2

IPI = 3

IPI = 4

IPI = 5

P < 0.001

C

D

20 40 60 80 100

20

40

60

80

100

Disease Free Survival (months)

Cu

mu

lati

ve S

urv

ival

(%

)

P = 0.011

IPI = 1

IPI = 0

IPI = 2

IPI = 3

IPI = 5

20 40 60 80 100

20

40

60

80

100

Overall Survival (months)

Cu

mu

lati

ve S

urv

ival

(%

)

Nasal

Non - nasal

Disseminated

P = 0.044

E

F

20 40 60 80 100

20

40

60

80

100

Disease Free Survival (months)

Cu

mu

lati

ve S

urv

ival

(%

)

Nasal

Non-nasal

Disseminated

P = 0.001

G